A Prospective Phase II Study of Apatinib Plus Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer

被引：0
|
作者：
Ma, K. [1 ]
Xu, Y. [1 ]
Cai, Y. [1 ]
Wang, X. [1 ]
Sun, C. [1 ]
Guo, Y. [1 ]
Qiu, S. [1 ]
机构：
[1] First Hosp Jilin Univ, Changchun, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
small-cell lung cancer; Apatinib; Phase II;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP10.05
引用
收藏
页码：S216 / S217
页数：2
相关论文
共 50 条
  • [41] Phase II trial of thalidomide with chemotherapy and as maintenance therapy for patients with poor prognosis small-cell lung cancer
    Lee, Siow Ming
    James, Lindsay
    Buchler, Tomas
    Snee, Mike
    Ellis, Paul
    Hackshaw, Allan
    LUNG CANCER, 2008, 59 (03) : 364 - 368
  • [42] A retrospective study of low-dose apatinib combined with S-1 in patients with advanced non-small cell lung cancer
    Zhou, Tong
    Wu, Changling
    Zhang, Changsong
    Li, Peng
    Dong, Huajie
    Zhou, Xiaoyue
    Lu, Hongjun
    Qi, Chuang
    Ling, Yang
    JOURNAL OF THORACIC DISEASE, 2019, 11 (05) : 1831 - 1837
  • [43] A Phase II Study of the Histone Deacetylase Inhibitor Panobinostat (LBH589) in Pretreated Patients with Small-Cell Lung Cancer
    de Marinis, Filippo
    Atmaca, Akin
    Tiseo, Marcello
    Giuffreda, Libero
    Rossi, Antonio
    Gebbia, Vittorio
    D'Antonio, Chiara
    Dal Zotto, Laura
    Al-Batran, Salah-Eddin
    Marsoni, Silvia
    Wolf, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (08) : 1091 - 1094
  • [44] Hypertension as a predictive biomarker in patients with advanced non-small-cell lung cancer treated with apatinib
    Fang, Shen-Cun
    Huang, Wen
    Zhang, Ying-Ming
    Zhang, Hai-Tao
    Xie, Wei-Ping
    ONCOTARGETS AND THERAPY, 2019, 12 : 985 - 992
  • [45] Apatinib monotherapy for advanced non-small cell lung cancer after the failure of chemotherapy or other targeted therapy
    Liu, Zui
    Ou, Wei
    Li, Ning
    Wang, Si-Yu
    THORACIC CANCER, 2018, 9 (10) : 1285 - 1290
  • [46] Phase II study of troxacitabine (BCH-4556) in patients with advanced non-small-cell lung cancer
    Dent, SF
    Arnold, A
    Stewart, DJ
    Gertler, S
    Ayoub, J
    Batist, G
    Goss, G
    Nevile, A
    Soulieres, D
    Jolivet, J
    McIntosh, L
    Seymour, L
    LUNG, 2005, 183 (04) : 265 - 272
  • [47] Phase II study of troxacitabine (BCH-4556) in patients with advanced non-small-cell lung cancer
    Dent S.F.
    Arnold A.
    Stewart D.J.
    Gertler S.
    Ayoub J.
    Batist G.
    Goss G.
    Nevile A.
    Soulieres D.
    Jolivet J.
    Mclntosh L.
    Seymour L.
    Lung, 2005, 183 (4) : 265 - 272
  • [48] Phase II study of nimustine hydrochloride (ACNU) plus paclitaxel for refractory small cell lung cancer
    Isobe, Kazutoshi
    Kobayashi, Kunihiko
    Kosaihira, Seiji
    Kurimoto, Futoshi
    Sakai, Hiroshi
    Uchida, Yuka
    Nagai, Yoshiaki
    Yamaguchi, Takefumi
    Miyanaga, Akihiko
    Ando, Makoto
    Mori, Gaku
    Hino, Mitsunori
    Gemma, Akihiko
    LUNG CANCER, 2009, 66 (03) : 350 - 354
  • [49] Carboplatin plus nab-paclitaxel for recurrent small cell lung cancer: A phase II study
    Ikeda, Naoya
    Arai, Ryo
    Soda, Sayo
    Inoue, Takashi
    Uchida, Nobuhiko
    Nakamura, Yusuke
    Masawa, Meitetsu
    Kushima, Yoshitomo
    Okutomi, Hiroaki
    Takemasa, Akihiro
    Shimizu, Yasuo
    Niho, Seiji
    THORACIC CANCER, 2022, 13 (09) : 1342 - 1348
  • [50] Phase II study of bevacizumab plus irinotecan on the treatment of relapsed resistant small cell lung cancer
    Trafalis, Dimitrios T.
    Alifieris, Constantinos
    Stathopoulos, George P.
    Sitaras, Nikolaos
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (04) : 713 - 722
12345